Σάββατο 29 Σεπτεμβρίου 2018

Low-Dose Multicomponent Medication Modulates Humoral And Cellular Immune Response In An Ex-Vivo Study On Children Subjected To Adenoid Surgery.

In conclusion, the present ex vivo study suggests that Citomix might be a promising medication in preventing and early treating respiratory infections. PMID: 30261195 [PubMed - as supplied by publisher] (Source: Immunology Letters)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.



from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2QfJxGo

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.